Bmi-1和c-myc在弥漫大B细胞淋巴瘤中的表达及其意义

    Expression and significances of Bmi-1 and c-myc in diffuse large B-cell lymphoma

    • 摘要: 目的: 研究Bmi-1和c-myc在弥漫大B细胞淋巴瘤(diffuse large B-cell lymphima,DLBCL)中的表达及相关性,探讨两者在DLBCL发生、发展中的作用及其临床意义。方法: 用免疫组织化学的方法检测60例DLBCL石蜡样本和20例淋巴结反应性增生(RH)组织中Bmi-1、c-myc的表达,并分析两者的相关性及其与DLBCL临床特征之间的关系。结果: Bmi-1和c-myc在DLBCL组织中的阳性表达分别为65.0%和75.0%,与对照组差异有统计学意义(P < 0.05~P < 0.01)。Bmi-1和c-myc的表达在临床分期及国际预后评分间差异均有统计学意义(P < 0.05~P < 0.01),在年龄、性别、结外侵犯、全身症状间差异均无统计学意义(P > 0.05)。结论: Bmi-1和c-myc在DLBCL的发生、发展中具有协同作用,可作为DLBCL的疗效和预后指标。

       

      Abstract: Objective: To study the expression and relationships of Bmi-1 and c-myc in diffuse large B-cell lymphoma (DLBCL) tissues and discuss their roles in carcinogenesis of DLBCL and explore their significances. Methods: The expressions of Bmi-1 and c-myc in 60 cases of DLBCL paraffins wax and 20 cases of benign lymph node lesions were detected by immunohistochemical method respectively. And the relationships of Bmi-1,c-myc and clinical parameters of DLBCL cases were analyzed. Results: The expression rate of Bmi-1 and c-myc in DLBCL was 65.0% and 75.0% respectively. Compared with the control, the difference was statitically significance(P < 0.05-P < 0.01). The expression of Bmi-1 and c-myc was related with clinical stage and international prognostic index(P < 0.05-P < 0.01),but there was no obvious correlation with its expression of the sex,age of patient,extranodal extension and clinical group(P > 0.05). Conclusions: Bmi-1 and c-myc had an synergistic effect in the development and progression of DLBCL and are useful in therapeutic and prognostic assessment.

       

    /

    返回文章
    返回